Incidence of hypertensive disorders of pregnancy and it’s maternal-fetal outcome in admitted antenatal patients in tertiary care centre, Bhilai, Chhattisgarh, India


  • Pooja Singh Department of Obstetrics and Gynecology, Shri Shankaracharya Institute of Medical Sciences, Bhilai, Chhattisgarh, India
  • Seema Khandasu Department of Obstetrics and Gynecology, Shri Shankaracharya Institute of Medical Sciences, Bhilai, Chhattisgarh, India
  • Rekha Ratnani Department of Obstetrics and Gynecology, Shri Shankaracharya Institute of Medical Sciences, Bhilai, Chhattisgarh, India



Hypertensive disorders of pregnancy, Maternal and fetal outcome, Pre-Eclampsia


Background: Pre-eclampsia refers to any new onset of hypertension and proteinuria after 20 weeks of gestation in a previously normotensive, non proteinuric women. Hypertension is a very common medical complication of pregnancy. It is one of the leading causes of maternal and fetal mortality and morbidity worldwide. Early detection, close surveillance and timely delivery are necessary to reduce complications and improvement in maternal and fetal health and outcome. To determine the incidence, risk factors and maternal and fetal outcomes in women with hypertensive disorders of pregnancy in all pregnant women attending Obstetrics and Gynaecology department, Shanakaracharya Institute of Medical Science, Bhilai.

Methods: This is a retrospective record-based observational study conducted over a period of one year from January 2020-December 2020 after getting approval from the institutional ethical committee. Patients diagnosed with hypertensive disorders of pregnancy were evaluated and data was collected and analyzed.

Results: Of the 1503 deliveries in the hospital during the period under review, 131(8.7%) were managed for hypertensive disorders of pregnancy. Pre-eclampsia was the commonest type of hypertensive disorder of pregnancy (69.3%) with the majority presenting with severe disease. Women of all age group were affected with highest incidence among 21-30years of age (69.4%). The incidence was maximum among primigravida (67.2%) compared to multipara 100 (32.8%). Intra uterine deaths were recorded among 12.2%, while a major share of fetus (41.2%) were diagnosed to have intrauterine growth retardation. Most common maternal complication in our study was abruption (7.6%), followed by HELLP (2.2%). Two maternal deaths were recorded, giving a case fatality rate of 1.5%.

Conclusions: Hypertensive disorders of pregnancy are associated with high maternal and fetal morbidity and mortality. Regular antenatal follow up will help in early diagnosis and timely intervention of the cases. Also, special consideration and close surveillance of those women with early-onset disease is important. There is need for strengthening of communication and referral systems in the healthcare.




The International Society for the Study of Hypertension in Pregnancy: The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice (Pregnancy Hypertension, 2018) ISSHP.

Cunningham FG, Lenovo KJ, Bloom SL, Dashe JS, Hoffman BL, Catherine YS. Williams Obstetrics. 25th ed. New York, NY: Mc Graw Hill Companies; 2018:710-754

Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011 Jun 21;123(24):2856-69.

Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. The Lancet global health. 2014 Jun 1;2(6):e323-33.

Trogstad L, Magnus P, Stoltenberg C. Pre-eclampsia: Risk factors and causal models. Best practice & research Clinical obstetrics & gynaecology. 2011 Jun 1;25(3):329-42.

Lippincott W. Wilkins. Hypertensive disorders in pregnancy. Manual of Obstetrics. 8th ed. Philadelphia, USA: Wolters Kluver Health. 2014:183-95.

American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstetrics and gynecology. 2013 Nov;122(5):1122-31.

Lawlor DA, Macdonald-Wallis C, Fraser A, Nelson SM, Hingorani A, Davey Smith G, Sattar N, Deanfield J. Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children. European heart journal. 2012 Feb 1;33(3):335-45.

Stuart JJ, Bairey Merz CN, Berga SL, Miller VM, Ouyang P, Shufelt CL, Steiner M, Wenger NK, Rich-Edwards JW. Maternal recall of hypertensive disorders in pregnancy: a systematic review. Journal of women's health. 2013 Jan 1;22(1):37-47.

Sengodan SS, Sreeprathi N. Prevalence of hypertensive disorders of pregnancy and its maternal outcome in a tertiary care hospital, Salem, Tamil Nadu, India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology.;9(1):237.

Gogaram PH, Misha S. Prevalence of pregnancy induced hypertension in Churu District. Indian Journal of Basic and Applied Medical Research. 2018;7(3):271-6.

Bindu KH, Devi EH. Effect of pregnancy induced hypertension on pregnancy outcome: a hospital based cross sectional study at a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2018;7950:1984-7

Kolluru V, Ramya Y, Harika, Kaul R. Maternal and perinatal outcome associated with pregnancy induced hypertension. Int J Reprod Contracept Obstet Gynecol. 2016;5(10):3367-71.

Belay Tolu L, Yigezu E, Urgie T, Feyissa GT. Maternal and perinatal outcome of preeclampsia without severe feature among pregnant women managed at a tertiary referral hospital in urban Ethiopia. PloS one. 2020 Apr 9;15(4):e0230638.






Original Research Articles